Bill Clinton Hails ‘Very Encouraging’ CBD Clinical Trial

Bill Clinton Hails ‘Very Encouraging’ CBD Clinical Trial

Clinical trials, According to researchers at the NYU Langone Health and Baptist Health / Jacksonville Orthopedic Institute, oral cannabidiol (CBD) -containing oral absorption tablets “safely manage pain after minimally invasive rotator cuff surgery and CBD. It did not cause side effects associated with use. Nausea, anxiety, liver toxicity, etc. “

Researchers at two research sites in Jacksonville, NYU Langone and Baptist Health, were 99 people who were “prescribed a low-dose Percocet” and “a placebo group between the ages of 18 and 75 and a group who received orally absorbed CBD.” Participants were randomly classified. I was instructed to stop the drug as soon as possible and take placebo / CBD three times a day for 14 days after surgery. “

“Patients who received CBD on the first day after surgery experienced an average of 23% less pain when measured by visual analog scale (VAS) pain scores compared to those who received placebo. It emphasizes that CBD can cause significant pain in patients with moderate pain. Benefits, “the researchers wrote in an analysis. “On both days 1 and 2 after surgery, patients who received CBD reported 22-25% more satisfaction with pain management than those who received placebo. The analysis also showed that patients receiving 50 mg of CBD reported lower pain and higher satisfaction with pain control compared to patients receiving placebo, with significant side effects reported. Is not.”

The results of this study were presented at the 2022 Annual Meeting of the American Orthopedic Association (AAOS) in Chicago in March.

On Monday, TR Processing LLC revealed that it is functioning as a CBD supplier for Orcosa Inc., the manufacturer of Oravexx used in clinical trials. This is an announcement with presidential approval.

In a press releaseTR Processing states that Clinton “has been investigating through the Clinton Foundation.”

The former president said the study was an important part of opioid addiction and efforts to reduce addiction in the United States. Citing data from the Center for Disease Control and Prevention, TR Processing said in a statement, “More than 100,000 Americans died from drug overdose in 2021 and 1 million lives in the last 20 years. Lost due to overdose. ” [that] US costs exceed $ 1 trillion annually. “

“The Clinton Foundation has been working for years to reduce opioid addiction and mortality. To be successful, we need a non-addictive alternative to pain management,” Clinton said in a statement. .. “The results of the tests conducted by NYU Langone using the CBD component of TRP are very encouraging and we would love to see the results of the next round.”

Michael J. Alaia, an associate professor of NYU orthopedics and principal investigator of the study, said: Repair of the rotator cuff. “

“This is a new and cheaper approach to providing analgesics and may not have the side effects of anti-inflammatory drugs like NSAIDs or the risk of opiate-related addiction. In addition, CBD has THC. It has the benefit of relieving the non-anti-inflammatory pain associated with and marijuana, “says Alaia.

“We are committed to supporting the research and responsible commercialization of isolated cannabinoids, including CBD,” said Chris Canary, chief strategy officer for TR processing.

“Tackling opioid abuse and addiction through the development of safer alternatives to pain management is the first of many potential uses of our proprietary processing platform, and we are enthusiastic about the future. Our work has great potential for precision medicine at its best, “says Canary.

With two decades of dedicated experience, Nuggs is a seasoned cannabis writer and grower. His journey has been a harmonious blend of nurturing cannabis from seed to harvest and crafting insightful content. A true expert, they've honed strain-specific knowledge, cultivation techniques, and industry insights. His passion shines through enlightening articles and thriving gardens, making them a respected figure in both the growing and writing facets of the cannabis world.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *